When you browse as many headlines and press releases as we do, you can tell when someone is trying hard to grab your attention:
Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment: Laser-type device to be coupled with Stem Cell Therapy in Novel Treatment Approach
It’s as though someone thought mentioning “laser” three times would get us to keep reading.
They were right.
How does it work? We can’t find too much on Entests’s website and the press release lacks many details but at least offers a clue:
Entest’s patent-pending approach revolves around the use of the patient’s own stem cells in combination with specific laser wavelengths in repairing damaged lung tissue of patients with COPD.
David Koos, President and CEO of Entest Biomedical, stated: “This LOI is the product of our previously announced discussions with manufacturers of laser-based therapies, in which we sought partners whose product portfolios and expertise matched Entest’s needs.
Sadly, based on further reading, it seems the lasers come into play during in vitro harvesting of stem cells; at no time are lasers and/or stem cells fired at patients.
More (but not much more) from Entest BioMedical…